The ideal approach is to take the injection on the same day each week
Gasoyan added that, in this large observational study of patients who discontinued semaglutide or tirzepatide, reinitiation of the original medication or receipt of alternative obesity treatment was common, which may explain why they regained less weight than patients in randomized trials. Additionally, previous research suggests that GLP-1 drug discontinuation often occurs for practical reasons rather than lack of effectiveness
In the context of GLP-1 therapy, glycine addresses the single biggest concern that clinicians and patients share: losing muscle along with fat
Additionally, an appropriate dietary and physical activity regimen is always the foundation of weight management and cardiovascular risk reduction
3.8 Biologics Generally Considered Compatible with Pregnancy 3.8.1 Certolizumab Certolizumab, a tumor necrosis factor-alpha (TNF) inhibitor, has very limited data regarding efficacy in HS [68]